Merck & Co announced plans to close eight research sites and eight manufacturing sites as it restructures in the wake of its merger with rival drugmaker Schering-Plough Corp. Merck's research network will include 16 major research and development facilities in the U.S., Belgium, England, France, Switzerland, Singapore and Japan. Merck will cut its manufacturing network from 91 facilities at the close of the deal in November to 77 facilities.
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
Oxea is returning to its old name and its roots.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Jens Birgersson becomes new Brenntag CEO
